$ABBV
AbbVie Inc.

2014 Q2 Form 10-Q Financial Statement

#000110465914058340 Filed on August 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q4 2013 Q2
Revenue $4.926B $5.111B $4.692B
YoY Change 4.99% -1.82% 4.43%
Cost Of Revenue $1.113B $1.286B $1.054B
YoY Change 5.6% 1.66% -1.77%
Gross Profit $3.813B $3.829B $3.638B
YoY Change 4.81% -2.84% 6.37%
Gross Profit Margin 77.41% 74.92% 77.54%
Selling, General & Admin $1.448B $1.448B $1.406B
YoY Change 2.99% 2.62% 12.84%
% of Gross Profit 37.98% 37.82% 38.65%
Research & Development $834.0M $783.0M $709.0M
YoY Change 17.63% 57.23% 10.44%
% of Gross Profit 21.87% 20.45% 19.49%
Depreciation & Amortization $103.0M $200.0M $100.0M
YoY Change 3.0% -35.28% -15.97%
% of Gross Profit 2.7% 5.22% 2.75%
Operating Expenses $2.282B $2.231B $2.115B
YoY Change 7.9% 16.87% 12.02%
Operating Profit $1.515B $1.598B $1.453B
YoY Change 4.27% -21.36% 2.18%
Interest Expense $73.00M -$79.00M $79.00M
YoY Change -7.59% 1.28% 3850.0%
% of Operating Profit 4.82% -4.94% 5.44%
Other Income/Expense, Net -$8.000M -$13.00M $4.000M
YoY Change -300.0% -56.67% -136.36%
Pretax Income $1.433B $1.439B $1.368B
YoY Change 4.75% -16.0% -2.43%
Income Tax $335.0M $311.0M $300.0M
% Of Pretax Income 23.38% 21.61% 21.93%
Net Earnings $1.098B $1.128B $1.068B
YoY Change 2.81% -26.75% -15.71%
Net Earnings / Revenue 22.29% 22.07% 22.76%
Basic Earnings Per Share $0.69 $0.70 $0.67
Diluted Earnings Per Share $0.68 $0.70 $0.66
COMMON SHARES
Basic Shares Outstanding 1.594B shares 1.589B shares
Diluted Shares Outstanding 1.608B shares 1.609B shares

Balance Sheet

Concept 2014 Q2 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.25B $9.895B $8.754B
YoY Change 17.04% 24.06% 11572.0%
Cash & Equivalents $9.086B $9.595B $8.743B
Short-Term Investments $1.160B $300.0M $11.00M
Other Short-Term Assets $2.689B $2.000B $2.068B
YoY Change 30.03% 0.55% 0.29%
Inventory $1.048B $1.150B $1.085B
Prepaid Expenses
Receivables $3.684B $3.854B $3.755B
Other Receivables $127.0M $949.0M $0.00
Total Short-Term Assets $17.79B $17.85B $15.66B
YoY Change 13.61% 16.24% 161.34%
LONG-TERM ASSETS
Property, Plant & Equipment $2.387B $2.298B $2.213B
YoY Change 7.86% 2.27% 5.78%
Goodwill $6.244B $6.277B $6.120B
YoY Change 2.03% 2.4%
Intangibles $1.695B $1.890B $2.101B
YoY Change -19.32% -18.64%
Long-Term Investments $130.0M $118.0M $121.0M
YoY Change 7.44% -0.84% -48.95%
Other Assets $795.0M $767.0M $1.693B
YoY Change -53.04% -8.14% 93.71%
Total Long-Term Assets $11.25B $11.35B $12.25B
YoY Change -8.14% -2.61% 4.53%
TOTAL ASSETS
Total Short-Term Assets $17.79B $17.85B $15.66B
Total Long-Term Assets $11.25B $11.35B $12.25B
Total Assets $29.05B $29.20B $27.91B
YoY Change 4.07% 8.11% 57.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.008B $933.0M $6.332B
YoY Change -5.12% 67.81% 1778.93%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $251.0M $413.0M $410.0M
YoY Change -38.78% -59.51%
Long-Term Debt Due $20.00M $18.00M $22.00M
YoY Change -9.09% -18.18%
Total Short-Term Liabilities $6.317B $6.879B $6.805B
YoY Change -7.17% 1.52% 40.6%
LONG-TERM LIABILITIES
Long-Term Debt $14.47B $14.29B $14.33B
YoY Change 1.01% -2.31%
Other Long-Term Liabilities $3.040B $1.337B $3.221B
YoY Change -5.62% 48.56% 135.97%
Total Long-Term Liabilities $17.51B $1.337B $17.55B
YoY Change -0.21% 48.56% 1185.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.317B $6.879B $6.805B
Total Long-Term Liabilities $17.51B $1.337B $17.55B
Total Liabilities $23.83B $8.216B $24.35B
YoY Change -2.16% 7.03% 292.52%
SHAREHOLDERS EQUITY
Retained Earnings $2.299B $1.567B $758.0M
YoY Change 203.3%
Common Stock $3.996B $3.671B $4.074B
YoY Change -1.91%
Preferred Stock
YoY Change
Treasury Stock (at cost) $673.0M $320.0M $121.0M
YoY Change 456.2%
Treasury Stock Shares 13.66M shares 6.900M shares 3.131M shares
Shareholders Equity $5.218B $4.492B $3.558B
YoY Change
Total Liabilities & Shareholders Equity $29.05B $29.20B $27.91B
YoY Change 4.07% 8.11% 57.59%

Cashflow Statement

Concept 2014 Q2 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income $1.098B $1.128B $1.068B
YoY Change 2.81% -26.75% -15.71%
Depreciation, Depletion And Amortization $103.0M $200.0M $100.0M
YoY Change 3.0% -35.28% -15.97%
Cash From Operating Activities $1.717B $1.245B $2.037B
YoY Change -15.71% 32.17% 30.49%
INVESTING ACTIVITIES
Capital Expenditures -$142.0M -$151.0M -$119.0M
YoY Change 19.33% 58.95% 26.6%
Acquisitions $134.0M
YoY Change
Other Investing Activities -$217.0M $274.0M $352.0M
YoY Change -161.65% -346.85% -425.93%
Cash From Investing Activities -$359.0M $123.0M $233.0M
YoY Change -254.08% -159.71% -215.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -415.0M -747.0M -500.0M
YoY Change -17.0% -131.27% -62.29%
NET CHANGE
Cash From Operating Activities 1.717B 1.245B 2.037B
Cash From Investing Activities -359.0M 123.0M 233.0M
Cash From Financing Activities -415.0M -747.0M -500.0M
Net Change In Cash 943.0M 621.0M 1.770B
YoY Change -46.72% -80.13% 5263.64%
FREE CASH FLOW
Cash From Operating Activities $1.717B $1.245B $2.037B
Capital Expenditures -$142.0M -$151.0M -$119.0M
Free Cash Flow $1.859B $1.396B $2.156B
YoY Change -13.78% 34.62% 30.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
AbbVie Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001551152
CY2013Q1 abbv Common Stock Distribution Ratio
CommonStockDistributionRatio
1 pure
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1591699124 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
abbv Number Of Principal Us Customers
NumberOfPrincipalUSCustomers
3 customer
CY2013Q2 abbv Separation Related Expenses
SeparationRelatedExpenses
67000000 USD
abbv Separation Related Expenses
SeparationRelatedExpenses
190000000 USD
abbv Separation Related Expenses
SeparationRelatedExpenses
100000000 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
73000000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
79000000 USD
us-gaap Interest Expense
InterestExpense
143000000 USD
us-gaap Interest Expense
InterestExpense
151000000 USD
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
10000000 USD
CY2014Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-69000000 USD
CY2013Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-75000000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-134000000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-141000000 USD
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
320000000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
485000000 USD
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
466000000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
404000000 USD
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
262000000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
136000000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
1150000000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
261000000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
1048000000 USD
us-gaap Depreciation
Depreciation
192000000 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1890000000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7147000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6909000000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4760000000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4611000000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2387000000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2298000000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
103000000 USD
CY2013Q2 us-gaap Depreciation
Depreciation
100000000 USD
us-gaap Depreciation
Depreciation
192000000 USD
us-gaap Participating Securities Distributed And Undistributed Earnings
ParticipatingSecuritiesDistributedAndUndistributedEarnings
11000000 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000000 shares
CY2014Q2 us-gaap Participating Securities Distributed And Undistributed Earnings
ParticipatingSecuritiesDistributedAndUndistributedEarnings
7000000 USD
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000000 shares
CY2013Q4 us-gaap Goodwill
Goodwill
6277000000 USD
CY2014Q2 us-gaap Goodwill
Goodwill
6244000000 USD
CY2014Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5750000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5738000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4501000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4295000000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1249000000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1443000000 USD
CY2014Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
446000000 USD
CY2013Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
447000000 USD
CY2014Q2 abbv Total Indefinite Lived Intangible Assets Excluding Goodwill
TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
446000000 USD
CY2013Q4 abbv Total Indefinite Lived Intangible Assets Excluding Goodwill
TotalIndefiniteLivedIntangibleAssetsExcludingGoodwill
447000000 USD
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6196000000 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6185000000 USD
CY2014Q2 abbv Accumulated Amortization Total
AccumulatedAmortizationTotal
4501000000 USD
CY2013Q4 abbv Accumulated Amortization Total
AccumulatedAmortizationTotal
4295000000 USD
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1695000000 USD
CY2014Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99000000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
271000000 USD
CY2014Q2 us-gaap Number Of Credit Risk Derivatives Held
NumberOfCreditRiskDerivativesHeld
0 item
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
17000000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
505000000 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
47000000 USD
CY2014Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
298000000 USD
CY2013Q4 abbv Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2000000 USD
CY2014Q2 abbv Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
2000000 USD
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
165000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
140000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-1000000 USD
CY2014Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
24000000 USD
CY2014Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0 USD
CY2014Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0 USD
CY2014Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0 USD
CY2014Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0 USD
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236 pure
CY2014Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2014Q2 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound
22000000 USD
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
4926000000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
4692000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
9489000000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
49000000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46000000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
9021000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
154000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
133000000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-38000000 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.20
CY2013Q1 us-gaap Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
1500000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5000000 shares
abbv Payments For Repurchase Of Common Stock On Open Market
PaymentsForRepurchaseOfCommonStockOnOpenMarket
250000000 USD
us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
1000000000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-442000000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-37000000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-59000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22000000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-420000000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1113000000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1448000000 USD
CY2014Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
834000000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1054000000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1406000000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
709000000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
3239000000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1453000000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14000000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1368000000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1068000000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2207000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2643000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1343000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6263000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2758000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-29000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19000000 USD
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.66
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1589000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1609000000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2607000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
571000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2036000000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.27
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1586000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1605000000 shares
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
3411000000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1515000000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1433000000 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1098000000 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.68
CY2014Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1594000000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1608000000 shares
us-gaap Costs And Expenses
CostsAndExpenses
6623000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2866000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2719000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2078000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2013Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
2000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
50000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-182000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-16000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-35000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
66000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
33000000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
11000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
68000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-137000000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1104000000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1136000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2100000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1899000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
5000000 USD
CY2013Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
9000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
9000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
18000000 USD
CY2014Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
251000000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9595000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
2000000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
2000000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
300000000 USD
CY2013Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3854000000 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
949000000 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
766000000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1234000000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
17848000000 USD
CY2013Q4 us-gaap Long Term Investments
LongTermInvestments
118000000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
767000000 USD
CY2013Q4 us-gaap Assets
Assets
29198000000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
17794000000 USD
CY2014Q2 us-gaap Assets
Assets
29045000000 USD
CY2013Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
413000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
18000000 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6448000000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6879000000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6317000000 USD
CY2013Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3535000000 USD
CY2013Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14292000000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
1160000000 USD
CY2014Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
3684000000 USD
CY2014Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
16000000 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
16000000 USD
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
320000000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3671000000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1567000000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
4492000000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29198000000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
5218000000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29045000000 USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4000000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1605362435 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1594260996 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13663311 shares
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6900434 shares
us-gaap Share Based Compensation
ShareBasedCompensation
133000000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
70000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-33000000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-585000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-136000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-182000000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3224000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
134000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
207000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
14000000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2075000000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1720000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-604000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1274000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
121000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
190000000 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-172000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-101000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2082000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-20000000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
2842000000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2341000000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1156000000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1692000000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-509000000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5901000000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8743000000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9086000000 USD
CY2013Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
70000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
17000000 USD
CY2014Q2 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
16000000 USD
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
16000000 USD
CY2014Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5000000 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-67000000 USD
abbv Payments For Repurchase Of Common Stock On Open Market
PaymentsForRepurchaseOfCommonStockOnOpenMarket
22000000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
335000000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2213000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2788000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1606000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
641000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-11000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-23000000 USD
CY2014Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
127000000 USD
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
1104000000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1585000000 USD
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
130000000 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
20000000 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
795000000 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6046000000 USD
CY2014Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
3040000000 USD
CY2014Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14470000000 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
673000000 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3996000000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2299000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
154000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
60000000 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-120000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-97000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
248000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-217000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
279000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1160000000 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
300000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-162000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
1314000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
353000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
127000000 USD
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
53000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-43000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2000000 USD
CY2014Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
0 USD
CY2013Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
0 USD

Files In Submission

Name View Source Status
0001104659-14-058340-index-headers.html Edgar Link pending
0001104659-14-058340-index.html Edgar Link pending
0001104659-14-058340.txt Edgar Link pending
0001104659-14-058340-xbrl.zip Edgar Link pending
a14-13926_110q.htm Edgar Link pending
a14-13926_1ex31d1.htm Edgar Link pending
a14-13926_1ex31d2.htm Edgar Link pending
a14-13926_1ex32d1.htm Edgar Link pending
a14-13926_1ex32d2.htm Edgar Link pending
abbv-20140630.xml Edgar Link completed
abbv-20140630.xsd Edgar Link pending
abbv-20140630_cal.xml Edgar Link unprocessable
abbv-20140630_def.xml Edgar Link unprocessable
abbv-20140630_lab.xml Edgar Link unprocessable
abbv-20140630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending